Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Various new pathogens in pneumonia]

C Regamey1

  • 1Clinique de médecine, Hôpital Cantonal, Fribourg.

Schweizerische Medizinische Wochenschrift
|November 11, 1995
PubMed
Summary
This summary is machine-generated.

Newly identified pathogens like drug-resistant Mycobacterium tuberculosis and Hantavirus cause severe respiratory infections. Early detection and new treatment strategies are crucial for managing these emerging infectious agents.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Occupational exposures with risk of transmission of HIV, HBC and HCV in health care workers].

Revue medicale suisse·2005
Same author

[Positive blood cultures during a 2 years period at Hôspital cantonal de Fribourg].

Revue medicale suisse·2005
Same author

[Blood culture negative endocarditis: a diagnostic challenge].

Revue medicale suisse·2005
Same author

Prospective epidemiologic survey of patients with community-acquired pneumonia requiring hospitalization in Switzerland.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2003
Same author

[Invasive meningococcal infections in the Fribourg canton. Reasons for and development of a vaccination program in Gruyere in February 2001].

Revue medicale de la Suisse romande·2001
Same author

[Cryoglobulins and endocarditis, a case report...].

Revue medicale de la Suisse romande·2001
Same journal

Respiratory function test in the case of temporary phrenic nerve contusion, associated with pneumoperitoneum; About the diagnostic value of laparoscopy.

Schweizerische medizinische Wochenschrift·2010
Same journal

Treatment of pulmonary tuberculosis and pleurisy by means of temporary paralysis of the diaphragm, supported by the pneumoperitoneum.

Schweizerische medizinische Wochenschrift·2010
Same journal

Boeck's disease as a tuberculous syndrome.

Schweizerische medizinische Wochenschrift·2010
Same journal

Enteral primary tubercular complexes

Schweizerische medizinische Wochenschrift·2010
Same journal

Tuberculous stenoses of the large bronchi.

Schweizerische medizinische Wochenschrift·2010
Same journal

About the enzyme action.

Schweizerische medizinische Wochenschrift·2010
See all related articles

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pulmonology

Context:

  • Emerging infectious agents are increasingly implicated in lower respiratory tract infections.
  • Traditional pathogens are evolving resistance, necessitating updated diagnostic and therapeutic approaches.
  • Novel viruses and bacteria pose significant public health challenges globally.

Purpose:

  • To review and highlight newly recognized microbial agents responsible for lower respiratory tract infections.
  • To discuss the diagnostic challenges and therapeutic implications associated with these emerging pathogens.
  • To underscore the importance of surveillance and strategic management of respiratory infections.

Summary:

  • Newly identified agents include drug-resistant Mycobacterium tuberculosis, Gram-positive cocci (Streptococcus agalactiae, Enterococci), Gram-negative rods (Acinetobacter, Aeromonas hydrophila, Eikenella corrodens), intracellular organisms, and viruses.

Related Experiment Videos

  • Specific focus is given to penicillin G-resistant Pneumococci, Chlamydia pneumoniae, Streptococcus pyogenes (associated with severe invasive infections), and pulmonary Hantavirus syndrome.
  • The pulmonary Hantavirus syndrome, particularly in North America, presents a high mortality rate, emphasizing the need for awareness and rapid diagnosis.

    • Impact:

    • Highlights the evolving landscape of respiratory pathogens, including antibiotic-resistant strains and novel viruses.
    • Stresses the need for enhanced diagnostic capabilities and the development of new therapeutic strategies.
    • Informs public health initiatives and clinical practice regarding the management of severe and invasive respiratory infections.